For LIS Technologies Inc., particular risks and uncertainties that could cause our actual future results to differ materially from those expressed in our forward-looking statements include but are not limited to the following which are, and will be, exacerbated by any worsening of global business and economic environment: (i) risks related to the development of new or advanced technology, including difficulties with design and testing, cost overruns, development of competitive technology, loss of key individuals and uncertainty of success of patent filing, (ii) our ability to obtain contracts and funding to be able to continue operations and (iii) risks related to uncertainty regarding our ability to commercially deploy a competitive laser enrichment technology, (iv) risks related to the impact of government regulation and policies including by the DOE and the U.S
Longer-term clinical outcomes by injection site have not been established by replicated, longer-duration studies
10.1128/aac.45.4.999-1007.2001 Antimicrob
This article explains what is happening physiologically, maps the typical arc so you know what is normal, flags the signals that warrant a clinician, and walks through the adjustments that reduce nausea in real life
Is pre-emptive surgery ever recommended